Identifi cation of novel Leishmania donovani antigens for development of second generation vaccine against Leishmaniasis
these antigens can be potential components of a future second generation antileishmanial vaccine. PDF HTML
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
these antigens can be potential components of a future second generation antileishmanial vaccine. PDF HTML
therapeutic effi cacy and its potential as immunopotentiating adjuvant may be explored. PDF HTML
alternative routes for the preparation of diffi cult to express sub-unit vaccines. PDF HTML
perform vaccine matching studies to support the effi cacy of actual vaccine formulations. PDF HTML
provides us with a model that should be followed when constructing synthetic cells. PDF HTML
immunity administered with or without adjuvants that may be suitable for human use. PDF HTML
demonstrated, opening the possibility of treating advanced lung cancer as a chronic disease. PDF HTML
elicited strong T cell and humoral responses upon a single oral gavage PDF HTML
have implications in the development of new antiviral agent for AIDS therapy. PDF HTML
mandate immunization education course and training as part of their core curriculum. PDF HTML
combined with almost any type of antigen that requires safe and potent adjuvants. PDF HTML
catch-up immunization for these groups will help to reduce hepatitis B transmission PDF HTML
Routine universal immunization is the main prevention strategies against disease burden in community. PDF HTML
plan to take steps to improve the acceptability of influenza vaccine by HCP. PDF HTML
made by MFDS as a national biological reference standard showed stable potency PDF HTML
will be conducted to estimate the reliable virus content with the candidate material. PDF HTML
analysis of predicted epitopes in different combinations for finding the most immunogenic combination. PDF HTML
diluted to standard vaccine potency and be used for animal immunization. PDF HTML
unit vaccine development for plague. Currently, we are performing in vivo protective study PDF HTML
propose our best approach in developing the next generation of herpes vaccine. PDF HTML
responsiveness and the HLA-genotype from each patient for future peptide vaccine design. PDF HTML
dimension to the malaria control program requiring formulation of the appropriate drug policy. PDF HTML
surface-exposed GPI-anchored antigens from the S.mansoni tegument as vaccine candidate. PDF HTML
immunized by pcSAG1 alone were indicated that enhanced efficacy of for pcSAG1 immunization. PDF HTML
approach directed at 10-50 years of age groups should also be considered PDF HTML
For authors and organisers
Find the right journal for your paper and submit your manuscript.